A detailed history of Deka Bank Deutsche Girozentrale transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 30,000 shares of BCYC stock, worth $440,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,000
Previous 30,000 -0.0%
Holding current value
$440,400
Previous $582,000 14.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$18.95 - $28.67 $318,360 - $481,656
16,800 Added 127.27%
30,000 $720,000
Q1 2022

Apr 28, 2022

BUY
$40.12 - $59.5 $48,144 - $71,400
1,200 Added 10.0%
13,200 $562,000
Q4 2021

Feb 02, 2022

BUY
$41.7 - $61.14 $500,400 - $733,680
12,000 New
12,000 $675,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.